Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Janssen has entered into a worldwide exclusive license and collaboration agreement with Protagonist to develop, manufacture, and commercialize PTG-200.
read more
ProSciento announced the appointment of Dr. Kelvin Logan, former President of Europe, Asia and Latin America at INC Research, to its Board of Directors.
read more
Frontida BioPharm announced the FDA issued a closure letter for its Philadelphia manufacturing site.
read more
BioPharma Services announced it has successfully completed three inspections this month by the FDA, with concurrent audits at both research centers in Toronto, Canada, and Columbia, Missouri.
read more
Saphetor announced a research partnership with the Exome Consortium of Link (UCL), led by Dr. Vincent Plagnol.
read more
Recipharm has appointmented Shabbir Mostafa to its Business Management team.
read more
Avista Pharma announced MMRF has contracted the company to manufacture an opioid-derived small molecule, a key component of a conjugate vaccine in development to treat opioid addiction.
read more
Optum and Merck will collaborate to develop and simulate the performance of contractual reimbursement models in which payment for prescription drugs is aligned more closely with patient health outcomes.
read more
ValSource announced Dr. James Vesper has joined as a Director, Learning Solutions.
read more
Hovione will initiate recruitment for its Phase 1 clinical trial of HY02, a proprietary minocycline sterile ointment to treat a subset of ocular surface inflammation, generally manifesting on the inner edge of the eyelids, leading to eye irritation ...
read more
JSR Life Sciences announced KBI Biopharma is expanding its biopharmaceutical manufacturing capacity and capabilities at both its Durham, North Carolina and Boulder, Colorado facilities.
read more
CURE announced it has received their first purchase order from their recently announced agreement with Meroven for the development of OTF delivery for several molecules.
read more
Lysogene announced it has entered into a manufacturing agreement with viral gene and cell therapy manufacturer Brammer Bio.
read more
Recro Gainesville has expanded its capabilities by adding a new tablet manufacturing suite and growing its development team.
read more
Pierre Fabre announced a purchase agreement to acquire several assets from biotechnology company Igenica Biotherapeutics.
read more